Our news

  • Today, evidence-based medicine is facing multiple serious challenges. Some claim that EBM has been hijacked by vested interests. We see an emphasis on surrogate outcomes with uncertain clinical value, on statistically significant results with marginal clinical benefit, and even outright manipulation of data. Publication bias and selective outcome...
    22 June 2017
  • Cochrane, a global independent network of researchers, professionals, patients, carers and people interested in health, is proud to announce its newest Associate Centre, Cochrane Sweden.The new Cochrane Sweden Centre is located in the city of Lund, and is affiliated with the Department of Research & Development / Section for HTA Analysis,...
    10 May 2017
  • With most votes of the 11 candidates, Professor Peter C. Gøtzsche joined the Cochrane Governing Board early in 2017. The Board is currently comprised of 13 members. Some are elected by the Cochrane Collaboration’s members and some are external directors appointed by the Board.Peter is one of the co-founders of Cochrane and has made a number of...
    10 May 2017
  • Women have been told for decades that they need to attend their routine breast screening appointments to detect early signs of breast cancer. However, a new major study, conducted by researchers at the Nordic Cochrane Centre in collaboration with researchers from Norway, looked into the effects of breast cancer screening programmes and have found...
    8 May 2017
  • Cochrane podcasts deliver the latest Cochrane evidence in an easy to access audio format, allowing you to stay up to date on newly published reviews wherever you are.Each Cochrane podcast offers a short summary of a recent Cochrane review from the authors themselves. They have been recorded in 33 languages and are brief, allowing everyone from...
    7 May 2017
  • On the 26th May 2016, Professor Peter C. Gøtzsche and Deputy Director Karsten Juhl Jørgensen, along with others, filed an official complaint about how the European Medicines Agency handled the HPV safety issue. Below is an overview of all correspondence about this complaint:  2nd February 2017 Follow-up of complaint to the...
    27 March 2017
  • Alpha-1 antitrypsin deficiency is an inherited disorder that can cause lung disease. It affects about 1 in 1600 to 5000 people. Those with lung disease suffer from shortness of breath, reduced ability to exercise and wheezing.People who smoke are more seriously affected and have a greater risk of dying from the disease. We reviewed the benefits...
    2 March 2016
  • Screening for breast cancer with mammography Screening with mammography uses X-ray imaging to find breast cancer before a lump can be felt. The goal is to treat cancer earlier, when a cure is more likely. The review includes seven trials that involved 600,000 women in the age range 39 to 74 years who were randomly assigned to receive...
    27 March 2013
  • General health checks involve multiple tests in a person who does not feel ill with the purpose of finding disease early, preventingdisease from developing, or providing reassurance. Health checks are a common element of health care in some countries. To manypeople health checks intuitively make sense, but experience from screening programmes for...
    2 March 2012
  • Placebo interventions are often claimed to substantially improve many clinical conditions. However, most reports on effects of placebosare based on unreliable studies that have not randomised patients to placebo or no treatment.We studied the effect of placebo treatments by reviewing 202 trials comparing placebo treatment with no treatment...
    27 March 2010

Pages

Subscribe to Our news